Ornithine Transcarbamylase Deficiency clinical trials

Explore recruiting ornithine transcarbamylase deficiency clinical trials.

Recruiting ornithine transcarbamylase deficiency studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ornithine Transcarbamylase Deficiency trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Long-Term Follow-up Study to Evaluate the Safety and Efficacy of Adeno-Associated Virus (AAV) Serotype 8 (AAV8)-Mediated Gene Transfer of Human Ornithine Transcarbamylase (OTC) in Adults with Late-Onset OTC Deficiency

France, Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 1/2/3 First-in-Human, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of a Single Intravenous (IV) Administration of ECUR-506 in Males Less than 9 Months of Age with Genetically Confirmed Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Adeno-associated Virus Serotype 8 (AAV8)-mediated Gene Transfer of Human Ornithine Transcarbamylase (OTC) in Patients with Late-onset OTC Deficiency

Spain, Netherlands, Italy, Portugal, France, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Long-term Follow-up (LTFU) Study of Participants in any iECURE Protocol Using an Investigational Product

Spain, France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Ornithine Transcarbamylase Deficiency trials by city

Ornithine Transcarbamylase Deficiency in Toronto Ornithine Transcarbamylase Deficiency in Vancouver Ornithine Transcarbamylase Deficiency in Montreal Ornithine Transcarbamylase Deficiency in Calgary Ornithine Transcarbamylase Deficiency in Edmonton Ornithine Transcarbamylase Deficiency in Ottawa Ornithine Transcarbamylase Deficiency in Winnipeg Ornithine Transcarbamylase Deficiency in Quebec City Ornithine Transcarbamylase Deficiency in Hamilton Ornithine Transcarbamylase Deficiency in Kitchener Ornithine Transcarbamylase Deficiency in London Ornithine Transcarbamylase Deficiency in Halifax Ornithine Transcarbamylase Deficiency in New York Ornithine Transcarbamylase Deficiency in Los Angeles Ornithine Transcarbamylase Deficiency in Chicago Ornithine Transcarbamylase Deficiency in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease